Related references
Note: Only part of the references are listed.The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R. Cox et al.
NATURE (2015)
LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
Roseli da Silva et al.
PLOS ONE (2015)
Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ
Hanibal Hani Adamo et al.
PLOS ONE (2015)
High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome
Viktor Tidehag et al.
EUROPEAN JOURNAL OF CANCER (2014)
Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
Emma Jernberg et al.
PLOS ONE (2013)
Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
Peter Hammarsten et al.
PLOS ONE (2012)
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
Christelle P. El-Haibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance
Andreas Josefsson et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2012)
Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies
Kristina A. Trujillo et al.
PROSTATE CANCER (2012)
Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome
Andreas Josefsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Lysyl Oxidase Contributes to Mechanotransduction-Mediated Regulation of Transforming Growth Factor-β Signaling in Breast Cancer Cells
Molly A. Taylor et al.
NEOPLASIA (2011)
H-1 HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples
Katarina Stenman et al.
BIOMARKER INSIGHTS (2011)
Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy
Anna Johansson et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients
Peter Hammarsten et al.
CLINICAL CANCER RESEARCH (2010)
Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival
Christina Hagglof et al.
PLOS ONE (2010)
Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes
Laura E. Pascal et al.
BMC CANCER (2009)
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Janine T. Erler et al.
CANCER CELL (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target
Stina Haggstrom Rudolfsson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling
A. H. Palamakumbura et al.
ONCOGENE (2009)
Evidence for Field Cancerization of the Prostate
Larisa Nonn et al.
PROSTATE (2009)
Low Stroma Androgen Receptor Level in Normal and Tumor Prostate Tissue Is Related to Poor Outcome in Prostate Cancer Patients
Pernilla Wikstrom et al.
PROSTATE (2009)
Extratumoral Macrophages Promote Tumor and Vascular Growth in an Orthotopic Rat Prostate Tumor Model
Sofia Halin et al.
NEOPLASIA (2009)
Paradoxical roles for lysyl oxidases in cancer - A prospect
Stacey L. Payne et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells
Min Wu et al.
CANCER RESEARCH (2007)
Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment
Sofia Halin et al.
PROSTATE (2007)
Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition
Peter Hammarsten et al.
CLINICAL CANCER RESEARCH (2006)
被撤回的出版物: Lysyl oxidase is essential for hypoxia-induced metastasis (Retracted article. See vol. 579, pg. 456, 2020)
JT Erler et al.
NATURE (2006)
How well does the gleason score predict prostate cancer death?: A 20-year followup of a population based cohort in Sweden
O Andrén et al.
JOURNAL OF UROLOGY (2006)
Lysyl oxidase expression in bronchogenic carcinoma
AR Woznick et al.
AMERICAN JOURNAL OF SURGERY (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The propeptide domain of lysyl oxidase induces phenotypic reversion of Ras-transformed cells
AH Palamakumbura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Investigating hypoxic tumor physiology through gene expression patterns
NC Denko et al.
ONCOGENE (2003)
Share Paper
